I am a trained clinical (neuropsychology) psychologist with research interest in finding affordable biomarkers for early diagnosis of AD in Nigeria and other resource poor setting.

Kazuhiko Uchida, M.D., Ph.D. is a Director of the Institute of Biomedical Research at Tsukuba, MCBI, in Japan. Dr. Uchida is a project leader of Clinical Bioinformatic Research Initiative focusing on blood-based biomarker discovery for early stages of cognitive impairment and other psychological diseases in collaboration with several University hospitals. Dr. Uchida has published more than 100 peer-reviewed articles in the basic and clinical research areas. He serves as principal investigator of several clinical intervention studies for dementia diagnosis and prevention.

Dr Chi Udeh-Momoh is Programme and Biomarker Lead with affiliations at Imperial College London, Karolinska Institute, Sweden, Aga Khan University, Kenya; and an Atlantic Fellow for Equity in Brain Health at the Global Brain health Institute, University of San Francisco, California. Having completed a competitive CASE PhD studentship in Neuroscience and Neuroendocrinology at the MRC Centre for Synaptic Plasticity at the University of Bristol (2010-2014), her current research focuses on elucidating dementia prevention bio-mechanistic pathways and strategies, also across diverse populations. In 2018, she initiated the WWFINGER-AFRICA project that aims to promote brain health and mitigate biomarker-access inequalities through culturally-sensitive sustainable multimodal intervention strategies in Sub-Saharan Africa, and identify related molecular mechanisms contributing to observed effects. She is co-Lead of the World-Wide FINGERS Biomarker Consortium, and on the Executive committee for the Biofluids-biomarker-based PIA of the Alzheimer’s Association ISTAART (2018 - present). She is also co-Founder of the Female Brain and Endocrine Research consortium (FEMBER). Chi leads multinational initiatives to address gender and racial disparities in medical research and academia, as part of the Opportunity Committee at Imperial College, and further sits on the Board of Trustees of the British Society for Neuroendocrinology as the Equality and Diversity Inclusion Lead.

https://www.linkedin.com/in/irem-ulku-47899b71/

Asli Uyar is a Computational Scientist at The Jackson Laboratory for Genomic Medicine. Her primary research interest is with Bioinformatics and ‘Cognitive Systems’ (Artificial Intelligence, Machine Learning). She develops computational methodologies which provide novel insight in disease modeling for more predictive and efficient preclinical studies. As part of the MODEL-AD consortium, she is working on studies investigating transcriptomic signatures in the brain of mouse models of both Early Onset and Late Onset Alzheimer’s Disease. The common goal of these studies is to provide effective mapping strategies for mouse-to-human inference by matching specific mouse models with Alzheimer’s Disease sub-types. In addition to her role as a research scientist, Asli is taking part in bioinformatics training programs teaching bioinformatics and machine learning workshops as a certified instructor for Software/Data Carpentry organizations.